By Dr. Priyom Bose, Ph.D. By replacing both breathing and circulatory buffering, a novel artificial lung bought critical time after lung removal, revealed irreversible damage, and made transplantation ...

The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...

Invisible particles in the air are not just irritating our lungs, they are quietly rewiring the immune system that is ...